Vaxx Populi

Vaxx Populi: The benefits of prioritizing by age—oldest first—are already showing. And clear, positive messaging works.

Vaxx Populi: Some scientists think using different types of vaccines might confer more protection against variants of concern. A study could provide the evidence.

Vaxx Populi: Seniors who don’t live in long-term care have largely gone unvaccinated in Canada, thanks to disruptions in vaccine shipments. Where are they in the queue now?

Vaxx Populi: A breakdown of doses expected versus doses received and how many people must be vaccinated every day in March to meet our first-quarter target

Vaxx Populi: Theoretically, the answer to the question should be a qualified yes, but new information—especially about the new variants—have experts counselling caution

Inside Canada’s impossibly high-stakes rush to lock down tens of millions of doses of the most sought-after product on Earth

Vaxx Populi: Trials are ongoing, which allow a window into how well Novavax’s vaccine stands up to emerging variants of COVID-19

Vaxx Populi: It’s relatively cheap to make and easy to store. But getting timely deliveries of this vaccine may be a problem.

Vaxx Populi: Canada’s contract with the pharmaceutical company for 40 million doses is based on five doses per vial. Pfizer wants it to be six.

Vaxx Populi: Israel has seen a precipitous drop in infection and hospitalization rates among those who’ve received a first dose, after 14 days